As part of wider updates to the Cochrane Handbook for Systematic Reviews of Interventions, Cochrane is publishing our first ever chapter dedicated to the conduct of living systematic reviews. This reflects the growing need for evidence that keeps pace with a rapidly evolving research landscape.

The Cochrane Collaboration has appointed its first Chief Community Officer, a dedicated senior role responsible for supporting and engaging Cochrane’s diverse global community.

We are pleased to announce that following the recent Governing Board election Isabelle Boutron, Director of Cochrane France and Moriam Chibuzor, Senior Research Officer at Cochrane Nigeria have been elected.

Cochrane is commissioning a series of new reviews to address priority questions identified by WHO. Given the importance of pre-eclampsia as a major cause of maternal and perinatal morbidity and mortality globally, these reviews have the potential to directly inform international recommendations and clinical practice.

An updated Cochrane review has found that ergonomic interventions show no meaningful benefit for pain, function, recovery or sick leave in workers with work-related complaints of the arm, neck or shoulder (CANS), compared with no treatment.

We are delighted to announce three hybrid discussions at the 2026 Cochrane Colloquium, creating new opportunities for community members to have your say on Cochrane’s future.

This year, World Evidence-based Healthcare Day is focusing on evidence, artificial intelligence (AI), and keeping people at the centre of health decision-making.

In this series, we profile those that have participated in the Cochrane International Mobility Program and learn more about their experiences.

A new Cochrane review finds that existing evidence is too uncertain to determine whether medical cannabis improves sleep or daytime functioning in people with insomnia.

Doctors’ prescribing habits are heavily influenced by payments, gifts, and free meals from pharmaceutical companies, leading to more expensive, less appropriate and more drugs being prescribed, a new Cochrane review finds.

In this series, we profile those that have participated in the Cochrane International Mobility Program and learn more about their experiences.

In this series, we profile those that have participated in the Cochrane International Mobility Program and learn more about their experiences.

We are looking author teams to take on a new Cochrane review in this area. Teams should be prepared to address the complexities inherent in reviews of pneumococcal vaccines, including the wide range of vaccine valencies available and the variation in vaccination schedules across countries.

We are looking for author teams with in-depth content knowledge to undertake one or more evidence synthesis which address some or all the uncertainties in this area.

Asthma management has evolved considerably. Digital health technologies, personalized asthma action plans, school-based support, remote monitoring, and multifaceted self-management programmes have become more common. That is why we are looking for author teams to take on a Cochrane review in this area.

Tobacco smoking during pregnancy remains a major public health concern and is associated with adverse outcomes for both pregnant women and infants. Effective interventions to support smoking cessation during pregnancy therefore continue to be a global healthcare priority. We are looking for author teams to update this review.

Depression and anxiety are among the leading causes of disability worldwide and place considerable burden on individuals, families, healthcare systems, and society. We are looking for author teams to take on a new Cochrane review in this area.

We are looking for author teams to take on this review assessing school‐based programmes for preventing smoking.

A tool for assessing the trustworthiness of randomized controlled trials (RCTs) has been published today in The BMJ, giving researchers a structured way to identify problematic studies before they're included in systematic reviews.

Emergency contraception containing mifepristone prevents more pregnancies with fewer side effects than some other common emergency contraceptive pills such as levonorgestrel, according to a new Cochrane review involving 87 trials.